Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Ameriprise Financial, Inc. (AMP)

Page 1 of 2

Ameriprise Financial, Inc. (NYSE:AMP) has seen an increase in hedge fund sentiment recently.

In the financial world, there are a multitude of methods investors can use to monitor stocks. A couple of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best fund managers can outperform their index-focused peers by a healthy amount (see just how much).

Ameriprise Financial, Inc. (NYSE:AMP)Equally as integral, positive insider trading sentiment is another way to parse down the marketplace. Just as you’d expect, there are lots of incentives for an insider to cut shares of his or her company, but just one, very clear reason why they would behave bullishly. Many empirical studies have demonstrated the impressive potential of this method if you know what to do (learn more here).

Keeping this in mind, let’s take a peek at the recent action regarding Ameriprise Financial, Inc. (NYSE:AMP).

What have hedge funds been doing with Ameriprise Financial, Inc. (NYSE:AMP)?

In preparation for this quarter, a total of 25 of the hedge funds we track were bullish in this stock, a change of 14% from the previous quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings meaningfully.

According to our comprehensive database, Steven Richman’s East Side Capital (RR Partners) had the largest position in Ameriprise Financial, Inc. (NYSE:AMP), worth close to $158.7 million, comprising 7.9% of its total 13F portfolio. The second largest stake is held by Cliff Asness of AQR Capital Management, with a $103.9 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Other hedge funds with similar optimism include Robert B. Gillam’s McKinley Capital Management, Phill Gross and Robert Atchinson’s Adage Capital Management and Israel Englander’s Millennium Management.

Consequently, specific money managers have been driving this bullishness. Columbus Hill Capital Management, managed by Kevin D. Eng, initiated the largest position in Ameriprise Financial, Inc. (NYSE:AMP). Columbus Hill Capital Management had 14.7 million invested in the company at the end of the quarter. Charles Davidson’s Wexford Capital also initiated a $13.7 million position during the quarter. The following funds were also among the new AMP investors: Patrik Brummer’s Zenit Asset Management AB, Neil Chriss’s Hutchin Hill Capital, and David Costen Haley’s HBK Investments.

What have insiders been doing with Ameriprise Financial, Inc. (NYSE:AMP)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past 180 days. Over the last six-month time frame, Ameriprise Financial, Inc. (NYSE:AMP) has seen zero unique insiders purchasing, and 12 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Ameriprise Financial, Inc. (NYSE:AMP). These stocks are The Blackstone Group L.P. (NYSE:BX), Principal Financial Group Inc (NYSE:PFG), T. Rowe Price Group, Inc. (NASDAQ:TROW), Invesco Ltd. (NYSE:IVZ), and Northern Trust Corporation (NASDAQ:NTRS). This group of stocks belong to the asset management industry and their market caps resemble AMP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!